top of page

ANCIENT WISDOM. MODERN SCIENCE.

Radiant Skin,
Naturally.

The world's first independently tested hirudin topical serum — proven safe for sensitive skin, proven stable, formulated for results.

Discover Now

CLINICALLY VERIFIED · 2025

Our Science →
20260103_143922.jpg

240

SUJECTS TESTED

EUROFINS CRL 2025

98.6%

NON- IRRITANT VIABILITY

OECD 439 STANDARD

12M

STABILITY CONFIRMED

12W ACCELERATED TESTING

0

ADVERSE EVENTS

PATCH TEST STUDY

Hirudin — Nature's Master Anticoagulant

Derived from medicinal leeches (Hirudo medicinalis) with 2,000 years of documented therapeutic use. 2% active concentration — independently verified safe for all Fitzpatrick skin types I–VI, including sensitive skin.

Precision Formulated

Two concentrations. One purpose — visibly calmer, clearer, more radiant skin. Every batch independently tested for purity, stability, and safety.

OUR COLLECTION

30 ML - DAILY RITUAL

Hirudin
Skin Serum

The essential introduction to hirudin skincare. Clinically tested, sensitive-skin approved, and precision-formulated at 2% active concentration for visible results.

✓ CLINICALLY TESTED      ✓ ZERO ADVERSE EVENTS   

✓ NON-IRRITANT VERIFIED

$100

View Details

100 ML — PROFESSIONAL

Hirudin
Skin Serum

The professional choice. Three months of daily ritual — the preferred option for clinics and practitioners seeking verified efficacy at scale.

✓ 3-MONTH SUPPLY      ✓ CLINICAL GRADE

✓ SAME CLINICAL DATA

$150

View Details

MOST POPULAR

Not a Claim.
A Proven Result.

THE EVIDENCE

Repeated Insult Patch Test

Eurofins | CRL, Inc.  · 240 subjects · ICH GCP

0 events

Skin Irritation Test — OECD 439

LifeNet Health LifeSciences · MatTek EpiDerm™

98.6%

12-Month Accelerated Cosmetic Stability Study

Eurofins | CRL, Inc. · Accelerated Aging

Stable

"

Under the conditions of this study, Hirudin Topical Serum did not demonstrate a potential for eliciting dermal irritation or inducing sensitization.

WINSTON MOY, MD · DIPLOMATE, AMERICAN BOARD OF DERMATOLOGY EUROFINS | CRL, INC. · STUDY ECRLNJ2025-0577

"Mean tissue viability of 98.6% — classified as No Category, Non-Irritant to Skin under the GHS standard."

— LifeNet Health LifeSciences, OECD 439 Study LNH-S-095-003

INDEPENDENTLY TESTED BY EUROFINS CRL · PISCATAWAY, NJ LIFENET HEALTH LIFESCIENCES · KALAMAZOO, MI

THREE CLINICAL REPORTS AVAILABLE FOR DOWNLOAD

bottom of page